Medical Network April 26th Imagine that, medical distribution, to be occupied by SF Express, Jingdong, Shentong, Post, DHL and other courier companies!
Maybe soon.
▍ State Post Bureau: Express company eats medicine distribution business
On April 16, the State Post Bureau issued a news, at the 5th Secretary General's office meeting in 2018, analysing the economic operation of the postal industry in the first quarter of this year, judging the current development situation, and deploying the next phase of key work.
The director of the State Post Bureau stated that in order to guide the postal service, express delivery companies should speed up the development of high-value-added services such as cold chain and pharmaceuticals.
In the eyes of the express delivery industry, cold chain and pharmaceutical distribution are big markets, and they are 'fat'. They must take this as their key breakthrough point and resolutely eat this business. It can be felt that there are various forces outside the pharmaceutical industry that are being carefully laid out. Quickly infiltrate, knock on the door of the relatively closed pharmaceutical industry, occupy the market.
Regardless of the network and speed, traditional pharmaceutical and pharmaceutical businesses are all inferior in their distribution, but it is the policy that truly expresses the confidence and motivation of express companies to enter the pharmaceutical industry.
▍ National policy support, express delivery into the pharmaceutical industry
On February 3, 2016, the State Council issued the "Decision on Cancellation of the Second Batch of 152 Implementation of Administrative Examination and Approval Matters in the Designated Places of the Central Government" (Guo Fa [2016] No. 9), canceling the administrative approval for the approval of third-party pharmaceutical logistics operations. Matters. The policy is liberalized. Third-party logistics meets standards and can enter the medical distribution.
On March 11, 2016, the State Administration of the People’s Republic of China released on “Promoting the pharmaceutical industry health "Guidelines for Development" (Guobanfa (2016) No. 11). It is expressed that we must give full play to the advantage of postal enterprises and delivery companies in the delivery network, and improve the supply of medicines in grassroots and remote areas.
On January 9, 2017, the State Council issued the “13th Five-Year Plan for Deepening Medical and Health Care System Reform” (Guo Fa [2016] No. 78). It explicitly encourages the development of green medicine logistics and the development of third-party logistics and cold-chain logistics.
After uploading, the Food and Drug Administration of all provinces across the country has issued supporting documents to encourage the development of third-party pharmaceutical logistics. Welcome to the pharmaceutical distribution field.
▍ Shun Feng, Jingdong, postal, etc.
This 'big gift', express delivery companies can't wait to 'smile satisfied'.
As early as March 2014, Shunfeng established the Pharmaceutical Logistics Division. Currently, from the perspective of warehousing and qualification, SF has 7 self-operated medicine warehouses, and 4 of them have been established (Guangzhou, Nanjing, Chengdu, Xi'an). The storage area exceeds 80,000 square meters; On the logistics network, 26 professional medicine transit sites have been completed and put into operation, and the Lingdan trunk line network covers 22 provinces across the country, with more than 960 districts and counties.
JD Medical Logistics has also developed rapidly. Currently it has started operations in Shandong, Hunan, Hebei, Anhui, etc. It has established cooperation with Sinopharm Group, Hongyuntang, Huayu Pharmaceutical, Fukang Pharmaceutical, and Guanglin Pharmaceutical. The provided medical warehouse distribution service covers all aspects of transportation vehicles, transportation drivers, trunk distribution, terminal distribution, etc. It can provide services such as acceptance, storage, storage, maintenance, and delivery of goods that meet the GSP certification requirements.
In addition, logistics companies such as postal services and DHL have been involved in different depths. drug Distribution business.
▍ ▍ ▍ ▍ : : : : 中 要
China medicine enterprise Niang Zhenggan, vice president of the Management Association, mentioned that at present, there are phenomena in China's pharmaceutical logistics companies that do both distribution and logistics. However, with the development of the market economy, the division of labor in the industry will be increasingly refined, and the original integrated business will gradually be divided. The future of pharmaceutical logistics will become a special format.
It is undeniable that the entry of third-party logistics will pose a great threat to the existing pharmaceutical distribution companies.
In particular, on February 9, 2017, the State Council issued “Opinions on Further Reforming and Perfecting the Drug Production, Distribution, and Use Policy” (Guobanfa [2017] No. 13), which supports the merger and reorganization of pharmaceutical circulation and fosters the development of large-scale modern pharmaceutical circulation enterprises. Promote the transformation of some enterprises into distribution and distribution modes.
Many small and medium-sized pharmaceutical distribution companies have been transformed into distribution, and there is no chance of winning the competition with these courier companies. From this perspective, the decline of small and medium-sized circulation enterprises is not suspenseful.
In the long run, this will definitely happen.
▍ May not be so fast, but be vigilant
However, a senior person who has been engaged in pharmaceutical logistics for many years told the author that in the short term, these companies can also stay on for a while.
He said that whether it is Jingdong or Shunfeng, the current business development has not been conceived smoothly. On the one hand, it is professional Talent The lack of talents in pharmaceutical logistics is still concentrated in traditional pharmaceutical and commercial companies. Although the above two companies have dug a lot of people from the industry, the overall situation is not enough.
At the same time, supervision has not yet fully liberalized, and the threshold is still there. This is also the reason why Shunfeng Jingdong cannot enter it alone, but must purchase local pharmaceutical companies or cooperate with local GSP-qualified commercial companies.
In addition, there are still regulatory blind spots for the drug transportation and use links, which are restricting the social logistics from entering the pharmaceutical industry.
Although these constraints still exist, in the long run, the veteran admits that it is only a matter of time before the express company enters the pharmaceutical industry. Perhaps in the near future, more companies will enter, Shentong, Yuantong.....
